Multiple Faces of Cerebral Small Vessel Diseases.
作者信息
Gurol M Edip, Sacco Ralph L, McCullough Louise D
机构信息
From the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (M.E.G.).
Department of Neurology, Miller School of Medicine, University of Miami, Coral Gables, FL (R.L.S.).
出版信息
Stroke. 2020 Jan;51(1):9-11. doi: 10.1161/STROKEAHA.119.027969. Epub 2019 Nov 22.
Abstract
摘要
相似文献
1
Multiple Faces of Cerebral Small Vessel Diseases.
Stroke. 2020 Jan;51(1):9-11. doi: 10.1161/STROKEAHA.119.027969. Epub 2019 Nov 22.
2
[Not Available].
Rev Med Interne. 2020 Jul;41(7):469-474. doi: 10.1016/j.revmed.2020.04.018. Epub 2020 Jul 24.
3
[Cerebral amyloid angiopathy revealed or hypertension-related cerebral small vessel diseases: A clinical challenge].
Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):279-282. doi: 10.1016/j.ancard.2019.07.006. Epub 2019 Aug 26.
4
Advanced Neuroimaging to Unravel Mechanisms of Cerebral Small Vessel Diseases.
Stroke. 2020 Jan;51(1):29-37. doi: 10.1161/STROKEAHA.119.024149. Epub 2019 Nov 22.
5
Teaching NeuroImages: MRI-visible Virchow-Robin perivascular spaces in cerebral small-vessel disease.
Neurology. 2014 Sep 16;83(12):e119-20. doi: 10.1212/WNL.0000000000000805.
6
Hypertensive Arteriopathy and Cerebral Amyloid Angiopathy in Patients with Cognitive Decline and Mixed Cerebral Microbleeds.
J Alzheimers Dis. 2020;78(4):1765-1774. doi: 10.3233/JAD-200992.
7
Cerebral Small Vessel Disease.
Cell Transplant. 2018 Dec;27(12):1711-1722. doi: 10.1177/0963689718795148. Epub 2018 Sep 25.
8
Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.
Neurology. 2017 Feb 28;88(9):878-884. doi: 10.1212/WNL.0000000000003655. Epub 2017 Jan 27.
9
A practical approach to the management of cerebral amyloid angiopathy.
Int J Stroke. 2021 Jun;16(4):356-369. doi: 10.1177/1747493020974464. Epub 2020 Nov 29.
10
[Not Available].
Praxis (Bern 1994). 2017;106(22):1215-1220. doi: 10.1024/1661-8157/a002806.
引用本文的文献
1
Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis.
Alzheimers Res Ther. 2025 Aug 7;17(1):183. doi: 10.1186/s13195-025-01815-6.
2
Predictors of Stroke Recurrence and Outcomes in Cerebral Small Vessel Disease: A Systematic Review of the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial Findings.
Cureus. 2025 Mar 28;17(3):e81393. doi: 10.7759/cureus.81393. eCollection 2025 Mar.
3
Umbelliferone as an effective component of Rhodiola for protecting the cerebral microvascular endothelial barrier in cSVD.
Front Pharmacol. 2025 Mar 17;16:1552579. doi: 10.3389/fphar.2025.1552579. eCollection 2025.
4
Etiology of Primary Cerebellar Intracerebral Hemorrhage Based on Topographic Localization.
Stroke. 2023 Dec;54(12):3074-3080. doi: 10.1161/STROKEAHA.123.044271. Epub 2023 Oct 16.
5
Relationship between cognitive dysfunction and the promoter methylation of PER1 and CRY1 in patients with cerebral small vessel disease.
Front Aging Neurosci. 2023 May 24;15:1174541. doi: 10.3389/fnagi.2023.1174541. eCollection 2023.
6
Editorial: Small vessel disease: From diagnosis to organized management pathways.
Front Neurol. 2023 Jan 10;13:1120426. doi: 10.3389/fneur.2022.1120426. eCollection 2022.
7
Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases.
Nutrients. 2023 Jan 9;15(2):334. doi: 10.3390/nu15020334.
本文引用的文献
1
Advanced Neuroimaging to Unravel Mechanisms of Cerebral Small Vessel Diseases.
Stroke. 2020 Jan;51(1):29-37. doi: 10.1161/STROKEAHA.119.024149. Epub 2019 Nov 22.
2
Clinical Relevance of Cerebral Small Vessel Diseases.
Stroke. 2020 Jan;51(1):47-53. doi: 10.1161/STROKEAHA.119.024148. Epub 2019 Nov 22.
3
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Lessons From Neuroimaging.
Stroke. 2020 Jan;51(1):21-28. doi: 10.1161/STROKEAHA.119.024152. Epub 2019 Nov 22.
4
Genetics of Cerebral Small Vessel Disease.
Stroke. 2020 Jan;51(1):12-20. doi: 10.1161/STROKEAHA.119.024151. Epub 2019 Nov 22.
5
New Treatment Approaches to Modify the Course of Cerebral Small Vessel Diseases.
Stroke. 2020 Jan;51(1):38-46. doi: 10.1161/STROKEAHA.119.024150. Epub 2019 Nov 22.
6
MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation.
Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.
7
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
J Neurol. 2019 May;266(5):1250-1259. doi: 10.1007/s00415-019-09256-6. Epub 2019 Mar 7.
8
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.
Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28.
9
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.
10
Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.
Stroke. 2018 Jan;49(1):247-254. doi: 10.1161/STROKEAHA.117.017081. Epub 2017 Dec 4.
Zotero 插件